Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1064

1.

Persistence of fluorescent nanoparticle-labeled bone marrow mesenchymal stem cells in vitro and after intra-articular injection.

Grady ST, Britton L, Hinrichs K, Nixon AJ, Watts AE.

J Tissue Eng Regen Med. 2018 Dec 7. doi: 10.1002/term.2781. [Epub ahead of print]

PMID:
30536848
2.

Mesenchymal Stem Cell Therapy in Osteoarthritis and Regenerative Medicine.

Freitag J, Kenihan MA.

Curr Sports Med Rep. 2018 Dec;17(12):441-443. doi: 10.1249/JSR.0000000000000541. No abstract available.

PMID:
30531461
3.

IL37 protects stem cell-based cartilage formation in an inflammatory OA-like micro-environment.

van Geffen E, van Caam APM, Vitters EL, van Beuningen HM, van de Loo FA, van Lent PLEM, Koenders MI, van der Kraan PM.

Tissue Eng Part A. 2018 Dec 10. doi: 10.1089/ten.TEA.2018.0267. [Epub ahead of print]

PMID:
30526407
4.

Targeting of chondrocyte plasticity via connexin43 modulation attenuates cellular senescence and fosters a pro-regenerative environment in osteoarthritis.

Varela-Eirín M, Varela-Vázquez A, Guitián-Caamaño A, Paíno CL, Mato V, Largo R, Aasen T, Tabernero A, Fonseca E, Kandouz M, Caeiro JR, Blanco A, Mayán MD.

Cell Death Dis. 2018 Dec 5;9(12):1166. doi: 10.1038/s41419-018-1225-2.

5.

Immunological modulation following bone marrow-derived mesenchymal stromal cells and Th17 lymphocyte co-cultures.

Najar M, Fayyad-Kazan H, Faour WH, Merimi M, Sokal EM, Lombard CA, Fahmi H.

Inflamm Res. 2018 Nov 30. doi: 10.1007/s00011-018-1205-0. [Epub ahead of print]

PMID:
30506263
6.

TGFβi is involved in the chondrogenic differentiation of mesenchymal stem cells and is dysregulated in osteoarthritis.

Ruiz M, Maumus M, Fonteneau G, Pers YM, Ferreira R, Dagneaux L, Delfour C, Houard X, Berenbaum F, Rannou F, Jorgensen C, Noël D.

Osteoarthritis Cartilage. 2018 Nov 28. pii: S1063-4584(18)31547-4. doi: 10.1016/j.joca.2018.11.005. [Epub ahead of print]

PMID:
30502449
7.

HDAC10 upregulation contributes to interleukin 1β-mediated inflammatory activation of synovium-derived mesenchymal stem cells in temporomandibular joint.

Liao W, Sun J, Liu W, Li W, Jia J, Ou F, Su K, Zheng Y, Zhang Z, Sun Y.

J Cell Physiol. 2018 Dec 4. doi: 10.1002/jcp.27873. [Epub ahead of print]

PMID:
30515817
8.

Biological Effects of Bone Marrow Concentrate in Knee Pathologies.

Fortier LA, Strauss EJ, Shepard DO, Becktell L, Kennedy JG.

J Knee Surg. 2018 Nov 30. doi: 10.1055/s-0038-1676069. [Epub ahead of print]

PMID:
30500973
9.

The effectiveness of allogeneic mesenchymal stem cells therapy for knee osteoarthritis in pigs.

Xia T, Yu F, Zhang K, Wu Z, Shi D, Teng H, Shen J, Yang X, Jiang Q.

Ann Transl Med. 2018 Oct;6(20):404. doi: 10.21037/atm.2018.09.55.

10.

Chondrogenic differentiation of adipose-derived mesenchymal stem cells induced by L-ascorbic acid and platelet rich plasma on silk fibroin scaffold.

Barlian A, Judawisastra H, Alfarafisa NM, Wibowo UA, Rosadi I.

PeerJ. 2018 Nov 19;6:e5809. doi: 10.7717/peerj.5809. eCollection 2018.

11.

In vitro and in vivo potentialities for cartilage repair from human advanced knee osteoarthritis synovial fluid-derived mesenchymal stem cells.

Neybecker P, Henrionnet C, Pape E, Mainard D, Galois L, Loeuille D, Gillet P, Pinzano A.

Stem Cell Res Ther. 2018 Nov 28;9(1):329. doi: 10.1186/s13287-018-1071-2.

12.

Adipose-Derived Stem Cell Treatments and Formulations.

Di Matteo B, El Araby MM, D'Angelo A, Iacono F, Nannini A, Vitale ND, Marcacci M, Respizzi S, Kon E.

Clin Sports Med. 2019 Jan;38(1):61-78. doi: 10.1016/j.csm.2018.08.004. Review.

PMID:
30466723
13.

Orthobiologics for Focal Articular Cartilage Defects.

Southworth TM, Naveen NB, Nwachukwu BU, Cole BJ, Frank RM.

Clin Sports Med. 2019 Jan;38(1):109-122. doi: 10.1016/j.csm.2018.09.001. Review.

PMID:
30466717
14.

Can mesenchymal stem cells and their conditioned medium assist inflammatory chondrocytes recovery?

Chen YC, Chang YW, Tan KP, Shen YS, Wang YH, Chang CH.

PLoS One. 2018 Nov 21;13(11):e0205563. doi: 10.1371/journal.pone.0205563. eCollection 2018.

15.

Intra-articular Mesenchymal Stem Cells in Osteoarthritis of the Knee: A Systematic Review of Clinical Outcomes and Evidence of Cartilage Repair.

Ha CW, Park YB, Kim SH, Lee HJ.

Arthroscopy. 2018 Nov 16. pii: S0749-8063(18)30616-9. doi: 10.1016/j.arthro.2018.07.028. [Epub ahead of print] Review.

PMID:
30455086
16.

On the mechanisms of action of the low molecular weight fraction of commercial human serum albumin in osteoarthritis.

Bar-Or D, Thomas G, Rael LT, Frederick E, Hausburg M, Bar-Or R, Brody E.

Curr Rheumatol Rev. 2018 Nov 19. doi: 10.2174/1573397114666181119121519. [Epub ahead of print]

PMID:
30451114
17.

Increased recruitment of endogenous stem cells and chondrogenic differentiation by a composite scaffold containing bone marrow homing peptide for cartilage regeneration.

Lu J, Shen X, Sun X, Yin H, Yang S, Lu C, Wang Y, Liu Y, Huang Y, Yang Z, Dong X, Wang C, Guo Q, Zhao L, Sun X, Lu S, Mikos AG, Peng J, Wang X.

Theranostics. 2018 Oct 5;8(18):5039-5058. doi: 10.7150/thno.26981. eCollection 2018.

18.

The Use of Platelet-Rich Plasma in Symptomatic Knee Osteoarthritis.

Southworth TM, Naveen NB, Tauro TM, Leong NL, Cole BJ.

J Knee Surg. 2018 Nov 13. doi: 10.1055/s-0038-1675170. [Epub ahead of print]

PMID:
30423591
19.

Scaffold-free cartilage cell sheet combined with bone-phase BMSCs-scaffold regenerate osteochondral construct in mini-pig model.

Wang F, Hu Y, He D, Zhou G, Ellis E 3rd.

Am J Transl Res. 2018 Oct 15;10(10):2997-3010. eCollection 2018.

20.

The Role of Wnt Pathway in the Pathogenesis of OA and Its Potential Therapeutic Implications in the Field of Regenerative Medicine.

De Santis M, Di Matteo B, Chisari E, Cincinelli G, Angele P, Lattermann C, Filardo G, Vitale ND, Selmi C, Kon E.

Biomed Res Int. 2018 Oct 15;2018:7402947. doi: 10.1155/2018/7402947. eCollection 2018. Review.

Supplemental Content

Loading ...
Support Center